Press release
Infectious Disease Therapeutics Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030 | CureVac SE, GeoVax, Inc., Hookipa Pharma Inc.
Global infectious disease therapeutics market is anticipated to grow at a CAGR of 7.8% during the forecast period (2023-2030). The market growth is attributed to the increasing prevalence of HPV, increasing FDA approvals rising supply of free infectious disease self-test kits, and raising awareness campaigns around the globe. According to the WHO, the global pooled prevalence was 31% for any HPV and 21% for high-risk HPV. HPV-16 was the most prevalent HPV genotype (5%) followed by HPV-6 (4%). HPV prevalence was high in young adults, reaching a maximum between the ages of 25 years and 29 years, Additionally, market players are also developing new products to treat infectious diseases and receiving approvals to commercialize their products. In February 2023, Becton, Dickinson, and Company, a global provider of medical technology company, received the US FDA market approval for the BD Onclarity™ HPV assay to be used with the BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test. The BD SurePath™ Liquid-based Pap Test vial and the Hologic ThinPrep® Pap Test PreservCyt® Solution vial are the two most common Pap vials used by laboratories in the US.To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/infectious-disease-therapeutics-market
Furthermore, the growing prevalence of malaria around the globe, and increasing funding activities for patients who have infectious diseases also enlarged the demand for infectious disease therapeutics. According to the WHO, malaria mortalities reduced steadily over the period 2000-2019, from 897,000 in 2000 to 577,000 in 2015 and to 568,000 in 2019 around the globe. In 2020, malaria mortalities increased by 10% compared with 2019, to an estimated 625,000. Estimated fatalities declined slightly in 2021 to 619,000. Between 2019 and 2021, 63,000 fatalities were due to disruptions to essential malaria services during the COVID-19 pandemic. Globally, the malaria mortality rate that is deaths per 100,000 population at risk split from about 30 in 2000 to 15 in 2015; it then continued to decrease but at a slower rate, falling to 14 in 2019. In 2020, the mortality rate increased again, to 15.1, before decreasing slightly to 14.8 in 2021.
Total funding for malaria control and elimination in 2021 was estimated at $3.5 billion, compared with $ 3.3 billion in 2020 and $3.0 billion in 2019. The amount invested in 2021 fell short of the $7.3 billion estimated to be required to stay on track toward the GTS milestones around the globe.
Market Coverage
• The market number available for - 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Disease Type
o By End-user
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
Competitive Landscape- includes, Novartis AG, Gilead, GlaxoSmithKline plc, Janssen Pharmaceutical, Inc., F. Hoffmann-La Roche Ltd., BioCryst Pharmaceuticals Inc., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Infectious Disease Therapeutics Market Report Segment
By Disease Type
• Human immunodeficiency viruses (HIV),
• Tuberculosis (TB),
• Influenza,
• Hepatitis,
• Human papillomavirus (HPV)
• Malaria
By End-User
• Hospital
• Clinics
A full report of Infectious Disease Therapeutics Market available @ https://www.omrglobal.com/industry-reports/infectious-disease-therapeutics-market
Global Infectious Disease Therapeutics Market Report Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Amgen Inc.
• Aspen Pharmacare Holdings Ltd.
• Boehringer Ingelheim GmbH
• Celltrion, Inc.
• Cidara Therapeutics, Inc.
• CureVac SE
• GeoVax, Inc.
• Hookipa Pharma Inc.
• Janssen Pharmaceutical (Johnson & Johnson)
• Lupin Pharmaceuticals, Inc.
• Merck & Co., Inc.
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Related Reports
https://ekz-crosstour.ch/news/der-weltweite-markt-fuer-molekulare-point-of-care-diagnostik-soll-bis-2030-56-milliarden-us-dollar-erreichen/141338/
https://www.somosxbox.com.mx/noticias-urgente/tamano-del-mercado-de-equipos-de-transmision-participacion-crecimiento-investigacion-y-pronostico-2022-2028/124401/
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Infectious Disease Therapeutics Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030 | CureVac SE, GeoVax, Inc., Hookipa Pharma Inc. here
News-ID: 3365585 • Views: …
More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033.
Infrastructure as Code (IaC) Service Market Overview
The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market…

Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033.
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview
The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,…

Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033.
Property Management Service Market Overview
The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly…

5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033.
5G Chipset Market Overview
The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT…
More Releases for HPV
Rising Prevalence Of HPV-Related Diseases Sparks Surge In Human Papillomavirus ( …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Human Papillomavirus (HPV) Vaccine Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, there's been speedy growth in the market size for the human papillomavirus (HPV) vaccine. Its worth is forecasted to increase from $5.8 billion in 2024 to $6.63 billion in 2025…
Global Human Papillomavirus (HPV) Vaccine Market Report 2025: Insights, Drivers …
The Global Human Papillomavirus (HPV) Vaccine Market size reached US$ 3,043.19 Million in 2024 and is expected to reach US$ 12,361.15 Million by 2033, growing at a CAGR of 16.9% during the forecast period 2025-2033.
The Human Papillomavirus (HPV) Vaccines Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data…
Rising Prevalence Of HPV-Related Diseases Sparks Surge In Human Papillomavirus ( …
The Human Papillomavirus (HPV) Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Human Papillomavirus (HPV) Vaccine Market Size During the Forecast Period?
The market size for the human papillomavirus (HPV) vaccine has seen swift growth in the past few years. The…
HPV Vaccines Market 2020-2026 - COVID19 Impact On HPV Vaccines Industry | Top Ke …
HPV Vaccines Market Size, Share & Industry Analysis, By Type (Bivalent and Polyvalent), By Disease Indication (HPV Associated Cancer and Genital Warts), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others) and Geography Forecast, 2019-2026.
Get Sample Copy Of Report To Know The Impact of Covid19 on this Industry: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/human-papillomavirus-hpv-vaccines-market-101962
Top Key Players: GSK, Merck.
An Overview of the Impact of COVID-19 on HPV Vaccines Market:
The emergence of COVID-19 has brought…
HPV Testing & PAP Test Market by Test Type (HPV Testing, Follow-up HPV Testing, …
Global HPV Testing & PAP Test Market was valued at USD XX billion in the year 2017. Global HPV Testing & PAP Test market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX billion by the year 2023.
Get Free Access to Sample Report @ https://genesismarketinsights.com/Sample_Request/GENRE385
In the Global HPV Testing & PAP Test Market, by region, North America holds the highest market share…
Cytology and HPV Testing Market: Disparate Levels of Awareness among Patients Re …
Over the years, the level of awareness among the global population regarding the various types of cancer has increased tremendously. The significance of early detection and diagnosis is not lost on them, resulting in the increased adoption of screening tests such as cytology and human papillomavirus (HPV) testing.
The global market for cytology and HPV testing is presented with a host of sustained growth opportunities arising mainly from several emerging economies,…